Ascelia Pharma AB (publ) (STO:ACE)

Ascelia Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.44	75.26	21.86	149.56	261.6	184.69
Cash & Short-Term Investments	60.44	75.26	21.86	149.56	261.6	184.69
Cash Growth	103.00%	244.34%	-85.39%	-42.83%	41.64%	0.25%
Other Receivables	3.85	6.1	2.99	5.16	5.87	2.83
Receivables	3.85	6.1	2.99	5.16	5.87	2.83
Prepaid Expenses	0.95	0.61	0.66	0.79	0.96	0.53
Other Current Assets	1.75	1.75	3.43	5.36	6.18	8.28
Total Current Assets	66.99	83.72	28.94	160.87	274.61	196.32
Property, Plant & Equipment	1.26	0.12	1.06	0.63	1.82	1.99
Other Intangible Assets	57.07	57.08	57.07	57.07	57.06	57.06
Other Long-Term Assets	-	-	-0	0	-	-
Total Assets	125.33	140.92	87.07	218.57	333.49	255.37
Accounts Payable	4.31	4.73	1.53	15.88	6.15	3.88
Accrued Expenses	18.2	12.73	8.52	19.66	16.34	12.98
Short-Term Debt	6.96	25.23	-	-	-	-
Current Portion of Leases	0.76	0.17	0.88	0.29	1.1	0.82
Current Income Taxes Payable	-	-	-	-	0.01	-
Other Current Liabilities	0.9	19.11	1.64	1.69	1.51	0.67
Total Current Liabilities	31.13	61.98	12.57	37.52	25.11	18.36
Long-Term Leases	0.49	-	0.18	0.19	0.55	0.96
Other Long-Term Liabilities	-	-	-	-0	-	-
Total Liabilities	31.62	61.98	12.74	37.71	25.66	19.32
Common Stock	117.11	97.19	34.87	34.87	34.58	28.7
Additional Paid-In Capital	744.66	721.75	678.75	678.75	678.83	493.73
Retained Earnings	-769.13	-740.97	-639.96	-533.73	-405.83	-286.49
Comprehensive Income & Other	1.07	0.97	0.67	0.97	0.25	0.12
Shareholders' Equity	93.71	78.94	74.33	180.86	307.83	236.06
Total Liabilities & Equity	125.33	140.92	87.07	218.57	333.49	255.37
Total Debt	8.21	25.4	1.06	0.48	1.66	1.78
Net Cash (Debt)	52.24	49.86	20.8	149.07	259.94	182.91
Net Cash Growth	-	139.76%	-86.05%	-42.65%	42.12%	-0.60%
Net Cash Per Share	0.59	0.92	0.62	4.28	7.89	6.96
Filing Date Shares Outstanding	112.96	96.11	33.76	33.67	33.67	28.19
Total Common Shares Outstanding	112.96	96.11	33.76	33.67	33.67	28.19
Working Capital	35.87	21.74	16.37	123.35	249.51	177.96
Book Value Per Share	0.83	0.82	2.20	5.37	9.14	8.37
Tangible Book Value	36.64	21.87	17.25	123.79	250.77	179
Tangible Book Value Per Share	0.32	0.23	0.51	3.68	7.45	6.35
Machinery	-	0.6	0.6	0.6	0.6	0.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.